Cargando…
Pediatric allogeneic stem cell transplantation from adult SARS-COV-2 positive donor
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is the cause of COVID-19. Almost 50% of infected people with the virus are asymptomatic. After the introduction of the COVID-19 vaccine, there is a significant reduction in symptomatic infection among vaccinated individuals. Th...
Autores principales: | Memon, Shahbaz, Mustafa, Rimaz, Essa, Mohammed, Al Zahrani, Mohsen, Alharbi, Musaed, Ahmari, Bader, Alsadi, Husam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Publishing Services by Elsevier B.V. on behalf of Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841470/ http://dx.doi.org/10.1016/j.phoj.2023.01.004 |
Ejemplares similares
-
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021) -
Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation
por: Mahmoud, Ebrahim, et al.
Publicado: (2022) -
Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma
por: Damlaj, Moussab, et al.
Publicado: (2018) -
Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
por: Bobadilla-Morales, Lucina, et al.
Publicado: (2015) -
Lobar pneumonia in pediatric patient with COVID-19
por: Kashgari, Amna, et al.
Publicado: (2020)